Pharvaris N.V. 4

CEO Berndt Modig sold 2,292 shares of Pharvaris N.V. common stock at about $34.97 per share under a Rule 10b5-1 trading plan.

On July 13, 2026, Pharvaris N.V. Chief Executive Officer Berndt Modig reported an open-market sale of 2,292 shares of Pharvaris N.V. common stock at a weighted average price of approximately $34.97 per share, for proceeds of roughly $80,000. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan and represents a small fraction of Modig’s overall holdings, which remain substantial both directly (132,917 shares) and indirectly through Schoodic Management BV, an entity he controls that holds an additional 950,000 shares. The filing notes that the sale aggregates multiple transactions within a price range of $34.68 to $35.11 and that some of the shares sold were originally acquired via vesting of restricted stock units over time, indicating a mix of routine portfolio and liquidity management rather than a wholesale reduction of his economic exposure to the company.

Filing Facts

CIK

1830487

Ticker

PHVS

Form

4

Source Type

fda

Accession

0001193125-26-304445

Alert Tier

5